Delivery Order SPM2D012D0007-A517

Award Date 9/24/15
Potential Completion Date 3/31/16
Potential Value $205K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lake Zurich, IL, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Fresenius Kabi USA, LLC, a foreign-owned, for-profit pharmaceutical company. The contract is for the delivery of 10 packages of 1 gram vials of Vancomycin Hydrochloride, a critical antibiotic medication. The contract is a firm-fixed-price delivery order with a total ceiling value of $681,975.76 and an ultimate completion date of March 31, 2016. This contract does not have a set-aside...
This is a delivery order contract awarded by the Defense Logistics Agency Troop Support Medical, a component of the Department of Defense, to Fresenius Kabi USA, LLC, a foreign-owned pharmaceutical company. The contract is for the delivery of 10 packages of 1 gram vials of vancomycin hydrochloride, an antibiotic medication, at a firm-fixed price of $97,711.52. The contract does not have a set-aside designation, indicating it was a full and open competition. This award was likely made against the...
This federal contract award, valued at $39,653.74, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company. The contract is for the delivery of 4,566,185,310 vials of the antibiotic drug vancomycin 1 gram, which is a critical medical treatment for military and federal healthcare facilities. The contract has an ultimate completion date of October 28, 2024, and is structured as a firm fixed-price...
This federal contract award is a delivery order (SPE2D020D0009|SPE2D325F0869) from the Defense Logistics Agency (DLA) Troop Support Medical division, a defense agency, to Fresenius Kabi, LLC, a foreign-owned pharmaceutical company based in Lake Zurich, Illinois. The $369,567.80 firm-fixed-price contract is for the delivery of 4,566,196,941 units of the antibiotic drug vancomycin in 1 gram vials. The contract has an ultimate completion date of October 29, 2024 and does not have a set-aside...
This is a delivery order contract awarded to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company, by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract, valued at $42,434.98, is for the delivery of Vancomycin 1 gram vials to federal government agencies. The contract is a firm fixed-price delivery order with an ultimate completion date of October 28, 2024. Fresenius Kabi is a significant supplier of critical care pharmaceuticals, focusing primarily...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The $12,220.60 firm fixed-price delivery order is for the supply of 1 gram vials of the antibiotic drug vancomycin, with an ultimate completion date of October 28, 2024. Fresenius Kabi is a major supplier of critical care pharmaceuticals, including injectable medications, infusion...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract, valued at $9,692.20, is a delivery order for the supply of 4,566,185,312 units of Vancomycin 1 gram vials. The contract has an ultimate completion date of October 28, 2024, and is a firm fixed-price contract. Fresenius Kabi, LLC is a significant supplier of critical care...
This is a $5,380.47 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,671,859 units of Vancomycin HCl 2 gram vials, a critical pharmaceutical product used in medical treatment. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This federal contract award, valued at $11,845.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,485,066 vials of Vancomycin Hydrochloride, a critical pharmaceutical product used in the treatment of various medical conditions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,869.80 firm fixed-price delivery order is for the supply of VANCOMYCIN 1 GRAM/200 ML BAG 200ML, a critical pharmaceutical product used in medical treatment. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
  • SPM2D012D0007
    Indefinite Delivery Contract
  • SPM2D012D0007-A517
    Delivery Order

This is a firm-fixed-price delivery order under the Pharmaceuticals and Drugs Federal Supply Schedule contract, awarded by the Defense Logistics Agency Troop Support Medical to Fresenius Kabi USA, LLC, a foreign-owned, for-profit pharmaceutical company. The contract is for the delivery of 10 packages of 1 gram vials of vancomycin hydrochloride, a critical antibiotic medication. The award has a ceiling value of $204,603.28 and a period of performance ending on March 31, 2016. This contract does not carry a set-aside designation, reflecting Fresenius Kabi's status as a large, foreign-owned business. The Department of Defense is the primary customer for this contract, which provides essential pharmaceutical products to support military healthcare needs.

Generated 4/2/25, 9:36 PM